论文部分内容阅读
目的回顾性分析评价FIGO解剖分期和预后评分在GTT治疗中的临床意义。方法选择有比较完整临床资料的已治GTT患者90例,根据2000年FIGO分期和评分标准,进行解剖分期和预后评分,并据此比较治疗的效果。结果绒癌组高危比例37.8%,侵蚀性葡萄胎组高危比例17.3%。解剖分期为Ⅰ期和Ⅲ期的低危组患者疗效好于同期高危组患者(P<0.05)。在复发的6例患者中,1例为低危,5例属高危者。给予综合治疗的17例疗效满意。结论绒癌患者存在高危因素者多于侵蚀性葡萄胎。在同期别中,低危患者疗效要好于高危者。治疗时应同时参考解剖分期和预后评分并有效利用综合治疗。
Objective To retrospectively evaluate the clinical significance of FIGO anatomy and prognosis in the treatment of GTT. Methods Totally 90 GTT patients with complete clinical data were selected. According to the FIGO staging and grading standards in 2000, the anatomic staging and prognostic score were compared and the effect of treatment was compared. Results The high risk of choriocarcinoma was 37.8%, and the high risk of invasive hydatidiform mole was 17.3%. Patients in the low-risk group with stage Ⅰ and Ⅲ were better than those in the high-risk group (P <0.05). Of the 6 patients who relapsed, 1 was low-risk and 5 was high-risk. 17 cases given comprehensive treatment of satisfactory results. Conclusion There are more risk factors for choriocarcinoma than aggressive mole. In the same period, the efficacy of low-risk patients is better than those at risk. Treatment should also refer to the anatomical stage and prognosis score and effective use of comprehensive treatment.